Aug 19, 2021 / 06:30AM GMT
Operator
Thank you all for standing by, and welcome to the quarterly report Q2 2021. (Operator Instructions) Please be advised that today's call is being recorded. I would now like to hand the call over to your CEO, Kjell-Erik Nordby. Thank you.
Kjell-Erik Nordby - Vistin Pharma ASA - CEO
Thank you. Welcome to the presentation of the second quarter and the first half 2021 results in Vistin Pharma. The presentation will be held by myself and the CFO in Vistin Pharma, Alexander Karlsen.
We start with a summary of the quarter. We had a record-high sales volume in the second quarter of 2021. However, the revenue was negatively affected by a significantly stronger NOK versus euro compared to the similar quarter last year. This resulted in a revenue of NOK 67 million versus NOK 73 million in the same quarter last year, an 8% decrease.
First -- the revenue for the first half of 2021 ended at NOK 138 million compared to NOK 134 million last year, which is a 2% growth.
EBITDA for the quarter ended at NOK 15.6 million versus NOK 20.9
Q2 2021 Vistin Pharma ASA Earnings Call Transcript
Aug 19, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers